Bristol Myers Squibb Company
430 E. 29th St
14th Floor
New York
New York
10016
United States
Tel: +1-800-332-2056
Website: http://www.bms.com/
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
We work every day to transform patients’ lives through science. Each day, our employees around the world work together for patients – they are at the center of everything we do. They inspire us. They are the reason we come to work each day.
We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
Possibility Lives at BMS!
2897 articles about Bristol Myers Squibb Company
-
Bristol-Myers Squibb Company Announces Extension of U.S. Agreement for ABILIFY(R) and Establishment of an Oncology Collaboration with Otsuka America Pharmaceutical, Inc.
4/6/2009
-
Bristol-Myers Squibb Company (JOBS) Wins Abilify Extension, Sees Profit Boost
4/6/2009
-
Ariad Pharmaceuticals, Inc. Appoints Former Bristol-Myers Squibb Company Senior Executive as New Independent Member of Its Board of Directors
4/6/2009
-
Bristol-Myers Squibb Company, AstraZeneca PLC ONGLYZA (saxagliptin) Cardiovascular Profile Acceptable According to FDA Advisory Committee; Rival to Merck & Co., Inc.'s Januvia Moves Closer to Approval
4/2/2009
-
Sanofi-Aventis K.K. And Bristol-Myers Squibb Company's Plavix Plus Aspirin Helps Prevent Strokes, McMaster University Study
4/1/2009
-
FDA To Review Bristol-Myers Squibb Company's New Diabetes Drug
4/1/2009
-
Bristol-Myers Squibb Company Release: Plavix(R) Plus Aspirin More Effective Than Aspirin Alone in Preventing Major Vascular Events in Patients with Atrial Fibrillation Who Cannot Take Oral Anticoagulants
3/31/2009
-
Eli Lilly and Company CEO Not Interested in Merger with Bristol-Myers Squibb Company
3/30/2009
-
Bristol-Myers Squibb Company Dapagliflozin Clinical Trial Results Indicate Improvement In Key Glycemic Measures In Treatment-Naïve Type 2 Diabetes Patients
3/27/2009
-
Bristol-Myers Squibb Company (JOBS) Settles FTC Probe
3/27/2009
-
Novo Nordisk A/S, AstraZeneca PLC-Bristol-Myers Squibb Company Diabetes Drugs Face U.S. Grilling
3/26/2009
-
Bristol-Myers Squibb Company Renews Contract With Cegedim Dendrite
3/25/2009
-
Bristol-Myers Squibb Company Executives Get Cash Not to Ride Private Jets; 61% Pay Raise to $59 Million
3/25/2009
-
BIOCON, Inc., Bristol-Myers Squibb Company (JOBS) Open New R&D Unit in Biocon Park, Bangalore; New Jobs Planned
3/25/2009
-
Bristol-Myers Squibb Company Gave CEO Total Pay Valued at $21.8 Million
3/24/2009
-
Bristol-Myers Squibb Company to Present at Healthcare Conference on March 17, 2009
3/17/2009
-
Bristol-Myers Squibb Company (JOBS) Enters Global Collaboration with Nissan Chemical Industries, Ltd. and Teijin Pharma on Novel Atrial Fibrillation Compound; Bristol to Pay $40 Million for Heart Drug
3/5/2009
-
Bristol-Myers Squibb Company Announces Dividend
3/4/2009
-
Bristol-Myers Squibb Company (JOBS) Changes Hint at CEO Succession Plan
3/4/2009
-
ZymoGenetics, Inc. Collaboration with Bristol-Myers Squibb Company Clears Review Under Hart-Scott-Rodino Antitrust Improvements Act
3/2/2009